TABLE 1.
Baseline patient characteristics (n = 31).
| Variables | Number of patient (%) |
|---|---|
| Median age (range) | 59 (32–77) |
| Sex | |
| Male | 20 (64.5) |
| Female | 11 (35.5) |
| Histology | |
| Clear cell carcinoma | 27 (87.1) |
| Non-clear cell carcinoma | 4 (12.9) |
| Comorbidities | |
| Hypertension | 6 (19.4) |
| Diabetes | 7 (22.6) |
| Others | 2 (6.5) |
| Previous nephrectomy | |
| Yes | 25 (80.6) |
| No | 6 (19.4) |
| ECOG performance status | |
| 0 | 3 (9.7) |
| 1 | 19 (61.3) |
| 2 | 7 (22.6) |
| 3 | 2 (6.5) |
| MSKCC risk group | |
| Favorable | 10 (32.3) |
| Intermediate | 16 (51.6) |
| Poor | 5 (16.1) |
| Number of metastasis | |
| 1 | 21 (67.7) |
| ≥2 | 10 (32.3) |
| Site of metastasis | |
| Lung | 16 (51.6) |
| Bone | 8 (25.8) |
| Liver | 2 (6.5) |
| Brain | 4 (12.9) |
| Local recurrence | 7 (22.6) |
| Adrenal | 3 (9.7) |
| Subcutaneous | 3 (9.7) |